Literature DB >> 7492353

Antigenic specificity of lymphocytes isolated from valvular specimens of rheumatic fever patients.

M Yoshinaga1, F Figueroa, M R Wahid, R H Marcus, E Suh, J B Zabriskie.   

Abstract

T cell lines were established from both valvular specimens and peripheral blood lymphocytes from seven patients with well documented rheumatic heart disease. These cell lines were stimulated with either PHA or streptococcal antigens. Proliferation assays revealed that both valvular and peripheral blood T cell lines reacted to cell wall (CW) and cell membrane (CM) antigens obtained from rheumatic fever associated group A streptococci and not to nephritogenic strains. None of the cell lines reacted to M protein, myosin or other mammalian cytoskeletal proteins. The unique reactivity of rheumatic fever T cell lines only to cellular structures obtained from rheumatogenic strains suggests that these lines react to epitopes specific for antigens obtained from these strains.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492353     DOI: 10.1016/0896-8411(95)90011-x

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  7 in total

1.  T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients.

Authors:  L Guilherme; S E Oshiro; K C Faé; E Cunha-Neto; G Renesto; A C Goldberg; A C Tanaka; P M Pomerantzeff; M H Kiss; C Silva; F Guzman; M E Patarroyo; S Southwood; A Sette; J Kalil
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  Immunogenic and Genetic Factors in Rheumatic Fever.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

Review 3.  Understanding rheumatic fever.

Authors:  Pedro Ming Azevedo; Rosa Rodrigues Pereira; Luiza Guilherme
Journal:  Rheumatol Int       Date:  2011-09-28       Impact factor: 2.631

4.  Preferential recognition of human myocardial antigens by T lymphocytes from rheumatic heart disease patients.

Authors:  M El-Demellawy; R El-Ridi; N I Guirguis; M Abdel Alim; A Kotby; M Kotb
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Vaccine strategies to prevent rheumatic fever.

Authors:  E R Brandt; M F Good
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 6.  Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease.

Authors:  Luiza Guilherme; Jorge Kalil
Journal:  J Clin Immunol       Date:  2009-10-03       Impact factor: 8.317

7.  Genes, autoimmunity and pathogenesis of rheumatic heart disease.

Authors:  L Guilherme; K F Köhler; E Postol; J Kalil
Journal:  Ann Pediatr Cardiol       Date:  2011-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.